These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 11309268

  • 1. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
    Hiramatsu M, Inoue K, Ambo A, Sasaki Y, Kameyama T.
    Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
    [Abstract] [Full Text] [Related]

  • 2. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH, Soong Y, Wu D, Qian X, Zhao GM.
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [Abstract] [Full Text] [Related]

  • 3. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 4. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.
    Eur J Pharmacol; 2000 Apr 28; 395(2):107-12. PubMed ID: 10794815
    [Abstract] [Full Text] [Related]

  • 5. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y, Zhou J, Liu X, Zhao L, Wang Z, Zhang X, Wang K, Wang L, Wang R.
    Peptides; 2017 May 28; 91():40-48. PubMed ID: 28363796
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relative contribution of peripheral versus central opioid receptors to antinociception.
    Labuz D, Mousa SA, Schäfer M, Stein C, Machelska H.
    Brain Res; 2007 Jul 30; 1160():30-8. PubMed ID: 17599812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H, Kon-No T, Watanabe H, Watanabe C, Yonezawa A, Sato T, Sakurada T, Sakurada S.
    Peptides; 2013 Dec 30; 50():139-44. PubMed ID: 24126280
    [Abstract] [Full Text] [Related]

  • 12. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN, Walker EA.
    J Pharmacol Exp Ther; 2003 Jan 30; 304(1):301-9. PubMed ID: 12490605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1996 Nov 30; 279(2):539-47. PubMed ID: 8930155
    [Abstract] [Full Text] [Related]

  • 15. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 30; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 16. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
    Zhao QY, Chen Q, Yang DJ, Feng Y, Long Y, Wang P, Wang R.
    Life Sci; 2005 Jul 22; 77(10):1155-65. PubMed ID: 15878600
    [Abstract] [Full Text] [Related]

  • 17. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M, Mizoguchi H, Kampine JP, Tseng LF.
    Br J Pharmacol; 1997 Feb 22; 120(4):587-92. PubMed ID: 9051295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 22; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.